280 related articles for article (PubMed ID: 16414520)
1. The effect of amblyopia therapy on ocular alignment.
Repka MX; Holmes JM; Melia BM; Beck RW; Gearinger MD; Tamkins SM; Wheeler DT;
J AAPOS; 2005 Dec; 9(6):542-5. PubMed ID: 16414520
[TBL] [Abstract][Full Text] [Related]
2. Effect of ocular alignment on emmetropization in children <10 years with amblyopia.
Kulp MT; Foster NC; Holmes JM; Kraker RT; Melia BM; Repka MX; Tien DR;
Am J Ophthalmol; 2012 Aug; 154(2):297-302.e1. PubMed ID: 22633344
[TBL] [Abstract][Full Text] [Related]
3. Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial.
Repka MX; Kraker RT; Holmes JM; Summers AI; Glaser SR; Barnhardt CN; Tien DR;
JAMA Ophthalmol; 2014 Jul; 132(7):799-805. PubMed ID: 24789375
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial to evaluate combined patching and atropine for residual amblyopia.
; Wallace DK; Kraker RT; Beck RW; Cotter SA; Davis PL; Holmes JM; Repka MX; Suh DW
Arch Ophthalmol; 2011 Jul; 129(7):960-2. PubMed ID: 21746992
[No Abstract] [Full Text] [Related]
5. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
Repka MX; Wallace DK; Beck RW; Kraker RT; Birch EE; Cotter SA; Donahue S; Everett DF; Hertle RW; Holmes JM; Quinn GE; Scheiman MM; Weakley DR;
Arch Ophthalmol; 2005 Feb; 123(2):149-57. PubMed ID: 15710809
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of atropine vs patching for treatment of moderate amblyopia: follow-up at age 10 years.
; Repka MX; Kraker RT; Beck RW; Holmes JM; Cotter SA; Birch EE; Astle WF; Chandler DL; Felius J; Arnold RW; Tien DR; Glaser SR
Arch Ophthalmol; 2008 Aug; 126(8):1039-44. PubMed ID: 18695096
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children.
Menon V; Shailesh G; Sharma P; Saxena R
J AAPOS; 2008 Oct; 12(5):493-7. PubMed ID: 18534880
[TBL] [Abstract][Full Text] [Related]
8. The clinical profile of moderate amblyopia in children younger than 7 years.
Pediatric Eye Disease Investigator Group
Arch Ophthalmol; 2002 Mar; 120(3):281-7. PubMed ID: 11879130
[TBL] [Abstract][Full Text] [Related]
9. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial.
Scheiman MM; Hertle RW; Kraker RT; Beck RW; Birch EE; Felius J; Holmes JM; Kundart J; Morrison DG; Repka MX; Tamkins SM;
Arch Ophthalmol; 2008 Dec; 126(12):1634-42. PubMed ID: 19064841
[TBL] [Abstract][Full Text] [Related]
10. "Combined Occlusion and Atropine Therapy" Versus "Augmented Part-Time Patching" in Children with Refractory/Residual Amblyopia: A Pilot Study.
Sachdeva V; Mittal V; Gupta V; Gunturu R; Kekunnaya R; Chandrasekharan A; Chabblani PP; Rao HL
Middle East Afr J Ophthalmol; 2016; 23(2):201-7. PubMed ID: 27162453
[TBL] [Abstract][Full Text] [Related]
11. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors.
Pediatric Eye Disease Investigator Group
Ophthalmology; 2003 Aug; 110(8):1632-7; discussion 1637-8. PubMed ID: 12917184
[TBL] [Abstract][Full Text] [Related]
12. Two-year follow-up of a randomized trial of spectacles plus alternate-day patching to treat strabismic amblyopia.
Agervi P; Kugelberg U; Kugelberg M; Zetterström C
Acta Ophthalmol; 2013 Nov; 91(7):678-84. PubMed ID: 22998746
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children.
Pediatric Eye Disease Investigator Group.
Arch Ophthalmol; 2002 Mar; 120(3):268-78. PubMed ID: 11879129
[TBL] [Abstract][Full Text] [Related]
14. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia.
Simons K; Stein L; Sener EC; Vitale S; Guyton DL
Ophthalmology; 1997 Dec; 104(12):2143-55. PubMed ID: 9400777
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of treatment of amblyopia in children aged 7 to 17 years.
Scheiman MM; Hertle RW; Beck RW; Edwards AR; Birch E; Cotter SA; Crouch ER; Cruz OA; Davitt BV; Donahue S; Holmes JM; Lyon DW; Repka MX; Sala NA; Silbert DI; Suh DW; Tamkins SM;
Arch Ophthalmol; 2005 Apr; 123(4):437-47. PubMed ID: 15824215
[TBL] [Abstract][Full Text] [Related]
16. Risk of amblyopia recurrence after cessation of treatment.
Holmes JM; Beck RW; Kraker RT; Astle WF; Birch EE; Cole SR; Cotter SA; Donahue S; Everett DF; Hertle RW; Keech RV; Paysse E; Quinn GF; Repka MX; Scheiman MM;
J AAPOS; 2004 Oct; 8(5):420-8. PubMed ID: 15492733
[TBL] [Abstract][Full Text] [Related]
17. The effect on refractive error of unilateral atropine as compared with patching for the treatment of amblyopia.
Repka MX; Melia M; Eibschitz-Tsimhoni M; London R; Magoon E;
J AAPOS; 2007 Jun; 11(3):300-2. PubMed ID: 17572346
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of penalization methods in moderate to mild amblyopia.
Tejedor J; Ogallar C
Am J Ophthalmol; 2008 Mar; 145(3):562-9. PubMed ID: 18207121
[TBL] [Abstract][Full Text] [Related]
19. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study.
Pediatric Eye Disease Investigator Group
Am J Ophthalmol; 2003 Oct; 136(4):630-9. PubMed ID: 14516802
[TBL] [Abstract][Full Text] [Related]
20. Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia.
Kaye SB; Chen SI; Price G; Kaye LC; Noonan C; Tripathi A; Ashwin P; Cota N; Clark D; Butcher J
J AAPOS; 2002 Oct; 6(5):289-93. PubMed ID: 12381987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
